Bactolife Raises Over €30M to Commercialize Precision Fermentation-Derived Binding Proteins
Danish company Bactolife has secured over €30 million in Series B funding to commercialize Binding Proteins, a new food, feed, and dietary supplement ingredient made using precision fermentation. The funding round was led by Cross Border Impact Ventures (CBIV) and EIFO (Danish Export and Investment Fund), with participation from existing investors Novo Holdings and Athos. The proceeds will be used to execute Bactolife’s human study program across the US, EU, …